Dishman Carbogen Amcis Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹851.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.28 per cent from ₹719.80 crore. This corresponds to a year-on-year *(YoY) growth of 18.85 per cent.
Operating Profit
Operating Profit stands at ₹161.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.05 per cent from ₹113.11 crore. This corresponds to a year-on-year *(YoY) growth of 14.80 per cent.
PBDT
PBDT stands at ₹134.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.37 per cent from ₹73.98 crore. This corresponds to a year-on-year *(YoY) growth of 26.34 per cent.
Profit Before Tax
Profit Before Tax stands at ₹46.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 541.86 per cent from ₹-10.44 crore. This corresponds to a year-on-year *(YoY) growth of 66.53 per cent.
Net Profit
Net Profit stands at ₹21.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 267.62 per cent from ₹-12.97 crore. This represents a 49.55 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Dishman Carbogen Amcis Ltd Earnings
- YOY
- QOQ
Dishman Carbogen Amcis Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dishman Carbogen Amcis Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Dishman Carbogen Amcis Ltd Financial Reports
Dishman Carbogen Amcis Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dishman Carbogen | 1.55% | 0.38% | 11.14% | 23.23% | -24.37% | -22.65% |
| Aarti Drugs | 0.65% | 5.41% | 8.72% | 13.34% | 3.80% | -15.52% |
| Panacea Biotec | 0.04% | 3.75% | 5.72% | 67.82% | 35.59% | 33.31% |
| Morepen Labs. | 1.64% | 1.69% | 30.76% | 54.06% | 59.88% | -1.42% |
| Hikal | -0.36% | 6.36% | 33.75% | 27.80% | 8.89% | -31.32% |
| Solara Active | 3.74% | 4.29% | 0.29% | 19.64% | 6.00% | -12.18% |
| Kwality Pharma | 1.60% | 0.90% | 12.82% | 78.58% | 144.42% | 125.57% |
Company Info
Company Information
WTD & Executive Director : Deohooti J Vyas
ED / Global MD / Promoter : Arpit J Vyas
Independent Non Exe. Director : KULIN NALINKANT SHAH
Independent Non Exe. Director : Hemantkumar J Bhatt
Independent Non Exe. Director : Margie S Parikh
Non-Exec & Non-Independent Dir : Dhaval R. Shah
Company Sec. & Compli. Officer : Shrima Dave